Wednesday, January 16, 2008

Endo News

RxTrials Institute Drug Pipeline Alert

Ipsen will provide funding for research programs in the field of proliferative diseases with a particular emphasis on novel therapeutic concepts for the treatment of pituitary adenomas, the company said...

This Topic on the Message Boards

FDA News


The Diagnosis of Polycystic Ovary Syndrome: The Criteria Are Insufficiently Robust for Clinical Research

Polycystic ovary syndrome (PCOS) is a common disorder but has considerable phenotypic variability and this has led to controversy over its exact definition and diagnosis. The objective of this study was to review the recently proposed diagnostic criteria to determine whether they were sufficiently robust for clinical and research practise...

This Topic on the Message Boards

MedScape

Labels:

0 Comments:

Post a Comment

<< Home